Management of Metastatic Breast Cancer in Frail Patients
NCT00005614
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
no accrual
Conditions
Breast Cancer
Interventions
DRUG:
Gemcitabine hydrochloride
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
[object Object]